0001104659-22-070220.txt : 20220610 0001104659-22-070220.hdr.sgml : 20220610 20220610172225 ACCESSION NUMBER: 0001104659-22-070220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220609 FILED AS OF DATE: 20220610 DATE AS OF CHANGE: 20220610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salsbury Michael CENTRAL INDEX KEY: 0001798308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37809 FILM NUMBER: 221009939 MAIL ADDRESS: STREET 1: 10 E. LEE STREET, APT. 2501 CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: (857) 702-9600 MAIL ADDRESS: STREET 1: 200 BERKELEY ST. STREET 2: FL 19 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Gemphire Therapeutics Inc. DATE OF NAME CHANGE: 20150331 4 1 tm2218193-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-09 0 0001638287 NeuroBo Pharmaceuticals, Inc. NRBO 0001798308 Salsbury Michael C/O NEUROBO PHARMACEUTICALS, INC. 200 BERKELEY STREET, OFFICE 19TH FLOOR BOSTON MA 02116 1 0 0 0 Nonstatutory Stock Option (right to buy) 0.4725 2022-06-09 4 A 0 20000 0 A 2032-06-09 Common Stock 20000 20000 D Vests on the earlier of June 9, 2023 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service. /s/ Michael Salsbury 2022-06-10